New Xultophy® (IDegLira) Phase 3b Trial Shows Improvements in Patient-Reported Outcomes Versus Insulin Glargine
Stockholm, Sweden (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. New findings from the DUAL(TM) V phase 3b clinical trial showed greater improvements in treatment-related satisfaction and patient-reported physical ...